The phase III ICE study: Adjudiscloseant Ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer Gunter.

Slides:

Advertisements

Similar presentations

Miles D et al. Proc SABCS 2012;Abstract P

Advertisements

Dr Antonio C. Buzaid Chefe Geral Centro Avançado de Oncologia

First Efficacy Results of a Randomized, Open- Label, Phase III Study of Adjuvant Doxorubicin Plus Cyclophosphamide, Followed by Docetaxel with or without.

Xeloda X-panding options in the adjuvant treatment of breast cancer

Implicaciones clínicas de los subtipos intrínsecos de cáncer de mama

Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple.

Rosario García Campelo Servicio de Oncología Médica

PRESUPUESTO ASIGNADO POLICÍA NACIONAL VIGENCIA 2012 (GESTIÓN GENERAL) Cifras en millones RECURSO 10: RECURSOS CORRIENTES RECURSO 16: FONDOS ESPECIALES.

1/03/09 De 89 à 98. 1/03/09 De 89 à 98 1/03/09 De 89 à 98.

OPEN ISSUES IN MULTIDISCIPLINARY BREAST CANCER MANAGEMENT

© 2013 RNA Diagnostics Inc. All rights reserved. Confidential 1 “RDA: better chemotherapy management” Investor Presentation April 2013.

Impact of Clinical Trials on Cancer Care in Low- and Middle – Income Countries Prof. Dra. Lucía Delgado Pebé Directora del Servicio de Oncología Clínica.

Phase Difference = Phase Difference = 0.05.

Key Issues in the Management of Metastatic Breast Cancer Case 2 (HER2 positive), v5 - July 3, to Abraxis Medical.

Current situation of Clinical Research in Latin America International Clinical Trials Workshop FLASCA, ASCO, NCI, ONS. September, Córdoba,

Targeting HER2 and Focusing on Patients With Gastric Cancer Jose Maria Vieitez, MD, PhD Assistant Professor of Oncology Department of Medical Oncology.

Extended duration of injection interval. 2 Lucas et al. Efficacy of lanreotide Autogel ® administered every 4–8 weeks in patients with acromegaly previously.

Matteo Lambertini, Marcello Ceppi, Francesca Poggio, Fedro A. Peccatori, Hatem A. Azim Jr., Donatella Ugolini, Paolo Pronzato, Sibylle Loibl, Halle C.

The Use of Trastuzumab in the Elderly in the Adjuvant Setting and After Disease Progression in Patients with HER2-Positive Advanced Breast Cancer Dall.

Lapatinib versus Trastuzumab in Combination with Neoadjuvant Anthracycline-Taxane-Based Chemotherapy: Primary Efficacy Endpoint Analysis of the GEPARQUINTO.

Breast cancer affects 1 in 8 women during their lives. 1 Population Statistics.

Gerber, B; Marx, M; Untch, M; Faridi, A Breast Reconstruction Following Cancer Treatment Dtsch Arztebl Int 2015; 112(35-36): ; DOI: /arztebl

1 Tampa Bay HealthCare Collaborative Getting a Better Return on Investment (ROI) for your Corporate or Community Health Fair.

Peters, E; Anzeneder, T; Jackisch, C; Dimpfl, T; Kunz, G; Katalinic, A; Waldmann, A The Treatment of Primary Breast Cancer in Older Women With Adjuvant.

Xeloda And Alcohol Consumption Purchase Xeloda Online much does xeloda cost oxiplatino y xeloda taxol xeloda xeloda procedure code xeloda and irinotecan.

Xeloda For Rectal Cancer Xeloda Online Coupon xeloda cost india xeloda antitumorale xeloda with avastin b6 xeloda xeloda traitement du cancer chemotherapie.

Xeloda Capecitabina Cheap Xeloda For Sale xeloda 500mg price in pakistan xeloda and depression medicamento xeloda 500 xeloda insert xeloda storage normal.

Response-Guided Neoadjuvant Chemotherapy for Breast Cancer Gunter von Minckwitz, Jens Uwe Blohmer, Serban Dan Costa, Carsten Denkert, Holger Eidtmann Journal.

Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials The Lancet Volume 386, Issue.

。 33 投资环境 3 开阔视野提升竞争力。 3 嘉峪关市概况。 3 。 3 嘉峪关是一座新兴的工业旅游城市，因关得名，因企设市，是长城文化与丝路文化交汇点，是全国唯一一座以长城关隘命名的城市。嘉峪关关城位于祁连山、黑山之间。 1965 年建市，下辖雄关区、镜铁区、长城区，全市总面积 2935.

HannaH phase III randomised study: Association of total pathological complete response with event-free survival in HER2-positive early breast cancer treated.

Elderly Women Ovarian Cancer Multicenter, randomized trial of carboplatin +/- paclitaxel in vulnerable elderly patients with stage III-IV advanced ovarian.

¿Qué ver en ASCO 2017?.

Volume 389, Issue 10087, Pages (June 2017)

Volume 387, Issue 10021, Pages (February 2016)

Mastectomy trends for early-stage breast cancer: A report from the EUSOMA multi- institutional European database Carlos A. Garcia-Etienne, Mariano Tomatis,

EL UNIVERSO ENDOTELIAL

Managing Metastatic Bone Pain: The Role of Bisphosphonates

Volume 4, Issue 5, Pages (September 2017)

Early Breast Cancer Clinical Trialists’ Collaborative Group

ASCO 2018 Tracing Tucatinib's Role in HER2+ Breast Cancer Treatment Published: Thursday, Jun 14, ESTUDOS DE FASE I: TUCATINIBE + TRASTUZUMABE +

Distinct Ezrin Truncations Differentiate Metastases in Sentinel Lymph Nodes from Unaffected Lymph Node Tissues, from Primary Breast Tumors, and from Healthy.

ФОНД ЗА РАЗВОЈ РЕПУБЛИКЕ СРБИЈЕ

سرطان الثدي Breast Cancer

Gastrointestinal Stromal Tumors: Disease and Treatment Update

Managing Metastatic Bone Pain: The Role of Bisphosphonates

المحاصيل السكرية - أ.د. عادل ابوسلامة

Eligibility Criteria and Genetic Testing Results from a High-Risk Cohort for Hereditary Breast and Ovarian Cancer Syndrome in Southeastern Ontario Ricardo.

Adjuvant Dose-Dense Chemotherapy in Breast Cancer: Standard of Care in High-Risk Patients Breast Care 2016;11: DOI: / Fig. 1. Strategies.

Volume 118, Issue 4, Pages (April 2000)

Early Versus Deferred Treatment With Combined Fludarabine, Cyclophosphamide and Rituximab (FCR) Improves Event-Free Survival In Patients With High-Risk.

Untch M et al. Proc SABCS 2010;Abstract P

Organ-Preserving Endoscopic Kidney Cancer Resection

Ovarian stimulation to cryopreserve fertilized oocytes in cancer patients can be started in the luteal phase Michael von Wolff, M.D., Christian J. Thaler,

Children’s Hospital Update

The Big 6 Research Model Step 3: Location and Access

Програмата е насочена към обновяване на многофамилни жилищни сгради, като с нея се цели чрез изпълнение на мерки за енергийна ефективност да се осигурят.

'III \-\- I ', I ,, - -

Gastrointestinal Stromal Tumors: Disease and Treatment Update

La Boutique Del PowerPoint.net

In focus – Emerging issues in cancer control

Volume 95, Issue 4, Pages (April 2019)

Volume 387, Issue 10021, Pages (February 2016)

Volume 383, Issue 9922, Pages (March 2014)

Journal of Thoracic Oncology

Maximizing Disease-Free Survival in Early-Stage HER2-Positive Breast Cancer.

Fig 2. Disease-free and overall survival in (A, B) responding, (C, D) nonresponding, and (E, F) all patients comparing response-guided with conventional.

Presentation transcript:

The phase III ICE study: Adjudiscloseant Ibandronate with or without capecitabine in elderly patients with moderate or high risk early breast cancer Gunter von Minckwitz, Toralf Reimer, Jochem Potenberg, Bettina Conrad, Heiko Graf, Holger Eidtmann, Marianne Just, Stephan Paepke, Elmar Stickeler, Georg Heinrich, Michael Untch, Volker Möbus, Christoph Thomssen, Christian Jackisch, Jens Huober, Sibylle Loibl, Valentina Nekljudova, Ulrike Nitz for the GBG / AGO-B / NOGGO / WSG study groups within the BIG framework Gunter von Minckwitz

Dra. María del Rosario Vidal Jefa del Servicio de Oncología Clínica del Hospital de Morón Estudio ICE Fase III: Ibandronato Adyuvante con o sin Capecitabina en Pacientes ancianas con cáncer de mama temprano con riesgo moderado o alto (GBG32, BIG 4-04) Gunter von Minckwitz, Toralf Reimer, Jochem Potenberg, Bettina Conrad, Heiko Graf, Holger Eidtmann, Marianne Just, Stephan Paepke, Elmar Stickeler, Georg Heinrich, Michael Untch, Volker Möbus, Christoph Thomssen, Christian Jackisch, Jens Huober, Sibylle Loibl, Valentina Nekljudova, Ulrike Nitz for the GBG / AGO-B / NOGGO / WSG study groups within the BIG framework